Market Access Jobs in Uccle

About the RoleWe are seeking a Brand Manager to prepare the launch and drive the national commercialisation of a key pharmaceutical this role you will be responsible for developing and executing the local marketing strategy translating global brand direction into impactful local plans and deliverin...

About the RoleWe are looking for an experienced Brand Manager to drive the national commercialisation of a key brand portfolio. This role is responsible for developing and executing the local marketing strategy translating global brand direction into impactful local plans and delivering budgetedor a...

At Roche you can show up as yourself embraced for the unique qualities you bring. Our culture encourages personal expression open dialogue and genuine connections where you are valued accepted and respected for who you are allowing you to thrive both personally and professionally. This is how we aim...

Role SummaryHigh-level summary of the position with main purpose of the position and how it will be successfully accomplished:The Business Unit Head is responsible for both Sales and Marketing and championing cross functional team working with medical market access and other functions as well as wor...

AstraZeneca is pushing the boundaries of science in order to deliver live-saving breakthrough medicines that will improve patients that endeavour Medical Affairs is a key strategic partner in shaping the optimal performance of the AstraZeneca brands. The Medical Affairs Manager is a core member of...

Government Affairs Lead at AZ BeLuxRole SummaryIn a fast-changing world marked by evolving healthcare policies rapid innovation and rising expectations from patients regulators and society strong and integrated corporate affairs are essential to advancing AstraZenecas purpose and business. The Gover...

Alexion is AstraZenecas Rare Disease unit focused on developing and delivering therapies for conditions with high unmet need particularly those involving complement system dysregulation and select metabolic/hematologic disorders. The portfolio includes Soliris (eculizumab) and Ultomiris (ravulizumab...